Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers develop new treatment to improve recovery after spinal cord injury
"This discovery is an exciting step in uncovering other possible combined treatments that have the potential to improve cell transplant therapy." Dr Jon Prager, RVC.

Teams create novel combined cellular and molecular treatment.

New research conducted by the Royal Veterinary College (RVC) in collaboration with the University of Bristol has led to the development of a new type of combined cell treatment that can help to improve recovery after spinal cord injury in companion animals and, ultimately, humans.

There is currently no cure for paralysis caused by damage to nerves in the spine, however, it is possible to inject cells from the nose – called olfactory ensheathing cells – into these damaged nerves. This has shown to improve walking in both experimental and companion animals and, though it is also known to be safe for humans, it has not been tested in a full clinical trial.

Another potential treatment is the injection of a molecule called chondroitinase. This has also improved recovery in experimental animals and pet dogs.

The research teams aimed to combine these two promising treatments into one, developing dog olfactory ensheathing cells that can create and release chondroitinase.

Injecting this new type of cell transplant into the spinal cord improved recovery of hand movements after spinal cord injury in rats. The treated subjects were shown to have increased accuracy when reaching and grasping compared to control subjects or those receiving cells alone.

Dr Jon Prager, postdoctoral researcher at the RVC, said: “Spinal cord injury causes chronic paralysis and incontinence, and remains a major worldwide healthcare burden, with no regenerative treatment clinically available. This study suggests that our genetically engineered cellular and molecular approach is a feasible combination therapy for spinal cord injury.

“Our findings show that this treatment leads to a modest improvement in rats’ ability to pick up treats and we are incredibly excited to see how the next stage of the research goes. This discovery is an exciting step in uncovering other possible combined treatments that have the potential to improve cell transplant therapy.”

Moving forward the researchers aims to test the efficacy of these treatments in ‘real-life’ injuries, such as those sustained by companion dogs and people.

The full paper is available to view here.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
RCVS Regional Question Time heads to Edinburgh

The RCVS is to bring its Regional Question Time (RQT) to Edinburgh for 2026.

The event will take place at Novotel Edinburgh Park in Edinburgh on Wednesday, 20 May 2026.

It will begin with supper and drinks at 6.30pm, with an evening programme from 7.30pm. This will start with an update on RCVS' activities, followed by questions and answers with representatives.

RCVS is encouraging an 'open dialogue', in which queries can be raised in a friendly, informal environment.

While discussions are expected to be audience-led, the RQT is expected address major issues including the VSA, the CMA's remedy package and the VN Vision project.

Tim Parkin, RCVS president, said: "It's an important time for the professions, and I'm looking forward to meeting colleagues in Scotland as we navigate this period of change together so we can come out stronger."

Tickets can be booked here.